Renewed interest in intrauterine contraception in the United States: Evidence and explanation

Contraception

Volumn 83, Issue 4, 2011, Pages 291-294

  Hubacher, David ^a   Finer, Lawrence B ^b   Espey, Eve ^c  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b GUTTMACHER INSTITUTE   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER INTRAUTERINE DEVICE; LEVONORGESTREL;

CONTRACEPTION; EVIDENCE BASED MEDICINE; FAMILY PLANNING; FOOD AND DRUG ADMINISTRATION; HUMAN; HYSTERECTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; MENSTRUATION DISORDER; NOTE; PRACTICE GUIDELINE; PREGNANCY; PREVALENCE; UNITED STATES;

ADOLESCENT; ADULT; CONTRACEPTION; FEMALE; HUMANS; INTRAUTERINE DEVICES; UNITED STATES; YOUNG ADULT;

EID: 79952573946     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.09.004     Document Type: Note

References (31)

1. Advisory Committee on Obstetrics and Gynecology. Report on Intrauterine Contraceptive Devices. United States Food and Drug Administration. Washington, DC: United States Government Printing Office; 1968.
2. Tietze C. Contraception with intrauterine devices. 1959-1966. Am J Obstet Gynecol 1966;96:1043-54.
3. Hubacher D, Cheng D. Intrauterine devices and reproductive health: American women in feast and famine. Contraception 2004;69:437-46. (Pubitemid 38638744)
4. Sivin I, Batar I. State-of-the-art of non-hormonal methods of contraception: III. Intrauterine devices. Eur J Contracept Reprod Health Care 2010;15:96-112.
5. Mosher W, Jones J. Use of contraception in the United States: 1982-2008. [June 1, 2010]; Available from: http://www.cdc.gov/nchs/data/series/sr-23/sr23- 029.pdf.
6. Boonstra H, Duran V, Northington Gamble V, Blumenthal P, Dominguez L, Pies C. The "boom and bust phenomenon": the hopes, dreams, and broken promises of the contraceptive revolution. Contraception 2000;61:9-25.
7. Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet 2000;356:1013-9.
8. Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992;339:785-8.
9. Hubacher D, Lara-Ricalde R, Taylor DJ, Guerra-Infante F, Guzman-Rodriguez R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 2001;345:561-7. (Pubitemid 32772097)
10. Mohllajee AP, Curtis KM, Peterson HB. Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review. Contraception 2006;73:145-53. (Pubitemid 43087764)
11. Kulier R, Helmerhorst FM, O'Brien P, Usher-Patel M, d'Arcangues C. Copper containing, framed intra-uterine devices for contraception. Cochrane Database Syst Rev 2006;3:CD005347.
12. Jones EF, Beniger JR, Westoff CF. Pill and IUD discontinuation in the United States, 1970-1975: the influence of the media. Fam Plann Perspect 1980;12:293-300.
13. Penney G, Brechin S, de Souza A, et al. FFPRHC Guidance (January 2004). The copper intrauterine device as long-term contraception. J Fam Plann Reprod Health Care 2004;30:29-41.
14. FFPRHC Guidance. The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health. J Fam Plann Reprod Health Care 2004;30:99-108 [quiz 9].
15. Weir E. Preventing pregnancy: a fresh look at the IUD. CMAJ 2003;169:585. (Pubitemid 37174602)
16. Chin J, Konje JC, Hickey M. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Cochrane Database Syst Rev 2009:CD007245.
17. Lethaby A, Irvine G, Cameron I. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev 2008:CD001016.
18. Pakarinen P, Luukkainen T. Treatment of menorrhagia with an LNGIUS. Contraception 2007;75:S118-S122.
19. Hubacher D, Grimes DA. Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv 2002;57:120-8. (Pubitemid 34132150)
20. Goodman S, Hendlish SK, Benedict C, Reeves MF, Pera-Floyd M, Foster-Rosales A. Increasing intrauterine contraception use by reducing barriers to post-abortal and interval insertion. Contraception 2008;78:136-42.
21. Trussell J, Wynn LL. Reducing unintended pregnancy in the United States. Contraception 2008;77:1-5.
22. Guttmacher Institute. Insurance coverage of contraceptives. 2010 [cited 2010 August 23]; Available from: http://www.guttmacher.org/statecenter/spibs/ spib-ICC.pdf.
23. Guttmacher Institute. State Medicaid family planning eligibility expansion. 2010 [cited 2010 August 23]; Available from: http://www.guttmacher. org/statecenter/spibs/spib-SMFPE.pdf.
24. ACOG. The intrauterine device. ACOG technical bulletin number 164-February 1992 (replaces no. 104, May 1987). Int J Gynaecol Obstet 1993;41:189-93.
25. ACOG practice bulletin. Clinical management guidelines for obstetrician- gynecologists. Number 59, January 2005. Intrauterine device. Obstet Gynecol 2005;105:223-32.
26. ACOG Committee Opinion No. 392, December 2007. Intrauterine device and adolescents. Obstet Gynecol 2007;110:1493-5.
27. Farr S, Folger SG, Paulen M, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition. MMWR Recomm Rep 2010;59:1-86.
28. World Health Organization. Medical eligibility criteria for contraceptive use. 3rd ed. Geneva: WHO; 2004 [cited 2010]; Available from: http://whqlibdoc.who.int/publications/2004/9241562668.pdf.
29. World Contraceptive Use 2009. United Nations; Available from: http://www.un.org/esa/population/publications/contraceptive2009/ contraceptive2009.htm.
30. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90-6.
31. Steiner MJ, Trussell J, Johnson S. Communicating contraceptive effectiveness: an updated counseling chart. Am J Obstet Gynecol 2007;197:118. (Pubitemid 47001858)